Back to Peptide Pedia
Cognitive & Nootropic
Well Researched

Semax

SMX

Nootropic and neuroprotective heptapeptide.

Also known as: ACTH(4-10) analog

Research dose range200–600 mcg daily (research models)
Route studiedIntranasal / subcutaneous
Study durationDaily, multi-week studies
Storage2–8 °C reconstituted

Overview

Semax is a synthetic peptide derived from a fragment of ACTH studied in cognition, neuroprotection, and BDNF-related research.

Key research findings

A synthetic analog of an ACTH(4-10) fragment, widely used in Russia as a nootropic and neuroprotective agent. Research highlights increased BDNF expression, improved focus and memory, and neuroprotection in stroke and cognitive-stress models — without the hormonal effects of full ACTH.

Mechanism of action

Studied for increasing BDNF and NGF expression and modulating the dopaminergic and serotonergic systems.

Molecular information

Weight813.9 Da
Length7 amino acids
TypeACTH(4-10) heptapeptide analog
Amino-acid sequenceMet-Glu-His-Phe-Pro-Gly-Pro

A Pro-Gly-Pro extension stabilizes the ACTH fragment against rapid breakdown.

Pharmacokinetics

Peak: ~0.25 hoursHalf-life: ~Minutes (intranasal onset fast)Cleared: ~24 hours
Peak · 1hHalf-life · 2h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Cognitive-enhancement research
  • Neuroprotection studies
  • BDNF/NGF-pathway investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Standard referenceAmount: 200–400 mcgFrequency: 1–2× dailyRoute: Intranasal
Higher-range referenceAmount: 600 mcgFrequency: Daily (divided)Route: Intranasal

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Acute

    Focus and alertness changes reported within ~30 minutes of intranasal dosing.

  2. Week 1–4

    BDNF-mediated cognitive and neuroprotective effects reported with continued use.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

NA-Semax Amidate

Stabilized variant of the same peptide — redundant.

Avoid combination

Selank

Frequently paired (focus + anxiolytic) in nootropic research.

Synergistic

P21

Complementary neurogenic/BDNF pathways.

Compatible

BPC-157

No known interactions, complementary mechanisms for stress response and neural protection

Compatible

TB-500

Both support brain health and recovery, can be used together for comprehensive neuroprotection

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. For intranasal use, many protocols prepare a metered spray.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Generally reported as well tolerated; nasal irritation is the most common intranasal signal.
  • Most clinical evidence originates from Russian research and is less replicated elsewhere.

References & further reading

Semax: ACTH(4-10) analog neuroprotection and cognition (review)

Human/preclinicalBDNFnootropic

Review of Semax's BDNF-related cognitive and neuroprotective effects across stroke and cognitive models.

View study

Topics

nootropicbdnfneuroprotection

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference
Dose range200–600 mcg daily (research models)
RouteIntranasal / subcutaneous
DurationDaily, multi-week studies
Storage2–8 °C reconstituted
Half-life~Minutes (intranasal onset fast)
Available at Reviva

Semax is stocked as a research-grade compound, ≥99% by HPLC, third-party verified.

View in catalogue